PE firm KV Asia seeks to exit its investment in Singapore-based Derma-Rx

PE firm KV Asia seeks to exit its investment in Singapore-based Derma-Rx

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter